Cargando…
Clinical significance of Wip1 overexpression and its association with the p38MAPK/p53/p16 pathway in NSCLC
Wip1 is deregulated in numerous human malignancies. However, its roles in non-small cell lung cancer (NSCLC) remain unclear. In the current study, the expression of Wip1 was investigated in NSCLC and its clinical significance was detected. Immunohistochemical staining was used to measure the express...
Autores principales: | Yang, Shize, Dong, Siyuan, Qu, Xiaohan, Zhong, Xinwen, Zhang, Qigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364870/ https://www.ncbi.nlm.nih.gov/pubmed/27959454 http://dx.doi.org/10.3892/mmr.2016.6032 |
Ejemplares similares
-
WIP1 promotes cancer stem cell properties by inhibiting p38 MAPK in NSCLC
por: Deng, Kaiyuan, et al.
Publicado: (2020) -
LZAP Inhibits p38 MAPK (p38) Phosphorylation and Activity by Facilitating p38 Association with the Wild-Type p53 Induced Phosphatase 1 (WIP1)
por: An, Hanbing, et al.
Publicado: (2011) -
Wip1 phosphatase: between p53 and MAPK kinases pathways
por: Goloudina, Anastasia R., et al.
Publicado: (2016) -
Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D
por: Castellino, Robert C., et al.
Publicado: (2007) -
Knockdown of Wip1 Enhances Sensitivity to Radiation in HeLa Cells Through Activation of p38 MAPK
por: Wang, Hong-yong, et al.
Publicado: (2015)